Synthetic peptide within Human DKK1 aa 250-350. The exact sequence is proprietary.
Positive control
JAR, HepG2, HeLa, and NCCIT cell lysates; Human placenta tissue; HeLa cells.
General notes
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
